Donate Now

How Should we Use Unproven Treatments during an Epidemic?

In 2013, the world began to witness an unprecedented Ebola epidemic in West Africa that is now smoldering. Ebola virus disease has a fatality rate of up to 90%, and there are no proven vaccines or targeted treatments for the disease to date. However, several interventions were in the earliest phases of testing at the beginning of this outbreak. Heated controversy quickly arose as to whether and how these unproven interventions should be used—among researchers, humanitarian health professionals, and the affected communities, but also among bioethicists.

Dr Annette Rid discusses the key points of ethical controversy and draws some important lessons for how we should use unproven vaccines and treatments during future epidemics.

 


This site use cookies.

Read more in Cookies Policy.

×

We need your help!

We host talks, concerts, exhibitions, courses, performances, community and social events. However, we are an independent charity and receive no funding from the government. Everything we do is dependent upon our commercial activity and the generosity of supporters like you.

Donate Now